Loading…
Indian life insurer controlled by ICICI Bank, selling savings, protection and investment-linked plans; formerly ICICI Prudential Life.
Indian life insurer controlled by ICICI Bank, selling savings, protection and investment-linked plans; formerly ICICI Prudential Life.
Earns by collecting premiums and charging fees on policyholders' investment funds; unit-linked plans, where customers carry the market risk and the insurer deducts charges, are a large part of the mix, so equity markets matter to sales. Many policies are sold through ICICI Bank branches, and ICICI Bank is the controlling owner. The 2026 rename drops Prudential, which is stepping back from promoter to ordinary investor.
In one line: A bank-owned, India-focused MetLife.
Moat: narrow (distribution, brand, scale). Selling through ICICI Bank's branches gives low-cost reach; products are otherwise easy to copy.
Headquarters: Mumbai, India · Founded: 2000 · Employees: 19,303
Size ICICI Life Insurance (ICICILIFE.NS) is an India Financials company (Life/Health Insurance) with a market value of $6.77B, the 167th largest of 1,058 India companies the cockpit tracks. Shares closed at ₹438.90 on 6 Nov 2026.
Performance Over six months the shares fell 22.0%, against +15.5% for the median peer and 0.0% for the India market (cap-weighted) — 2nd lowest of 21 in its peer set.
Growth Revenue fell 8.4% over the last twelve months (peer median +18.0%); the operating margin is 4.4% (peer median 9.0%).
Valuation It trades at 4.67× book value against a peer median of 2.41× (6th most expensive of 20).
Price implies The share price implies a return on equity of about 65.0%; ICICI Life Insurance delivers 12.6%, so the price asks more than the business earns today.
Next results Next results expected around 19 Jan 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | ₹646B | ₹636B | ₹704B | ₹910B | ₹507B |
| Revenue growth | — | -10% | -23% | +80% | — |
| Net income | ₹16.1B | ₹16.1B | ₹11.9B | ₹8.51B | ₹8.13B |
| Free cash flow | n/a | -₹54.8B | -₹96.7B | -₹62.5B | ₹11.0B |
| Capital expenditure | n/a | ₹1.23B | ₹2.59B | ₹2.37B | ₹1.93B |
| Total debt | ₹25.9B | ₹25.9B | ₹26.0B | ₹12.0B | ₹12.0B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | ROE | Price / book | Implied ROE |
|---|---|---|---|---|---|---|
| ICICI Life Insurance ICICILIFE.NS | $6.77B | -22% | -8% | 13% | 4.67× | 65.0% |
| SBI Life Insurance SBILIFE.NS | $18.9B | -5% | +18% | 14% | 8.72× | 105.4% |
| HDFC Life Insurance HDFCLIFE.NS | $13.0B | -10% | +19% | 11% | 6.31× | 72.0% |
| Life Insurance Corp. of India LICI.NS | $53.0B | -3% | +11% | 7% | 0.68× | 11.8% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | ICICILIFE.NS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -4.1% | +2.4% | 5th lowest of 21 |
| 6-month return | -22.0% | +15.5% | 2nd lowest of 21 |
| Return on equity | 12.6% | 11.5% | 9th highest of 21 |
| Price / book | 4.67× | 2.41× | 6th most expensive of 20 |
| Trailing P/E | 39.8× | 13.7× | 4th most expensive of 19 |
| ROE the price implies | 65.0% | 18.2% | 4th most demanding of 19 |
| ROE delivered | 12.6% | 11.7% | 9th highest of 20 |
| Company | Market | Market cap | 6M return | Revenue growth | ROE | Price / book | Implied ROE | Delivered ROE |
|---|---|---|---|---|---|---|---|---|
| ICICI Life Insurance ICICILIFE.NS | India | $6.77B | -22% | -8% | 13% | 4.67× | 65.0% | 12.6% |
| St. James's Place STJ.L | United Kingdom | $7.48B | -3% | +164% | 38% | 3.64× | 43.3% | 38.4% |
| Challenger CGF.AX | Australia | $5.59B | +36% | -25% | 13% | 2.01× | 15.8% | 13.3% |
| Jackson Financial Incorporation JXN | United States | $8.70B | +17% | +34% | 9% | 1.10× | 12.5% | 9.5% |
| Voya Financial VOYA | United States | $8.91B | +21% | -3% | 14% | 2.34× | 17.2% | 14.3% |
| Primerica PRI | United States | $8.94B | +6% | +8% | 33% | 3.56× | 24.9% | 32.9% |
| E-L Financial ELF.TO | Canada | $4.74B | +10% | +32% | 20% | 0.68× | 6.4% | 20.2% |
| Max Financial Services MFSL.NS | India | $4.68B | -25% | +18% | 3% | 7.71× | 78.7% | 3.3% |
| Medibank Private MPL.AX | Australia | $9.94B | +14% | +9% | 27% | 5.90× | 23.8% | 26.8% |
| JAPAN POST INSURANCE 7181.T | Japan | $11.2B | +8% | -6% | 4% | 0.38× | 2.9% | 4.2% |
| Standard Life SDLF.L | United Kingdom | $12.5B | +25% | +135% | -179% | 38.09× | n/a | -179.3% |
| HDFC Life Insurance HDFCLIFE.NS | India | $13.0B | -10% | +19% | 11% | 6.31× | 72.0% | 11.2% |
| Star Health & Allied Insurance STARHEALTH.NS | India | $3.52B | +9% | +21% | 12% | 3.19× | 47.7% | 11.7% |
| T&d 8795.T | Japan | $14.0B | +21% | +6% | 9% | 1.32× | 5.6% | 9.3% |
| Equitable EQH | United States | $14.1B | +24% | +6% | -183% | n/a | n/a | n/a |
| COFCO Capital 002423.SZ | China | $3.15B | -11% | -31% | 6% | 0.85× | 6.2% | 5.6% |
| Privia Health PRVA | United States | $3.12B | +6% | +24% | 4% | 3.94× | 25.4% | 3.8% |
| Corebridge Financial CRBG | United States | $14.9B | +25% | +10% | 22% | 2.41× | 19.3% | 21.7% |
| Reinsurance Group of America RGA | United States | $17.1B | +24% | +20% | 12% | 1.25× | 8.0% | 11.7% |
| Kgi Financial 2883.TW | Taiwan | $17.3B | +60% | +32% | 14% | 1.33× | 7.1% | 14.4% |
| Clover Health Investments CLOV | United States | $2.56B | +54% | +54% | -5% | 6.32× | 94.7% | -5.1% |